Will Dillard's (DDS) Beat Estimates Again in Its Next Earnings Report? — Positive
DDS Zacks Investment Research — August 01, 2025Dillard's (DDS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Why Bilibili (BILI) Could Beat Earnings Estimates Again — Positive
BILI Zacks Investment Research — August 01, 2025Bilibili (BILI) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Will Five Below (FIVE) Beat Estimates Again in Its Next Earnings Report? — Positive
FIVE Zacks Investment Research — August 01, 2025Five Below (FIVE) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Sarepta Therapeutics (SRPT) Announces Restructuring and ELEVIDYS Black Box Warning, EMA Recommends Refusal of Marketing Authorization, Securities Class Action Pending – Hagens Berman — Neutral
SRPT GlobeNewsWire — August 01, 2025SAN FRANCISCO, Aug. 01, 2025 (GLOBE NEWSWIRE) -- On July 16, 2025, Sarepta Therapeutics (NASDAQ: SRPT) announced a major restructuring that involves, in part, a 36% workforce reduction (500 employees) and other steps to annually save about $400 million. The company also agreed with the FDA to include a black box warning of acute liver injury and acute liver failure in Sarepta's ELEVIDYS label. ELEVIDYS is the company's gene therapy drug intended to treat a limited category of people with Duchenne muscular dystrophy.

Bill Baruch, founder and president at Blue Line Capital, joins CNBC's “Halftime Report” to explain why he's buying Thermo Fisher here.

The J.M. Smucker Company (SJM) Faces Investor Scrutiny After Announcing The Second Hostess-Related Impairments In About 3 Months – Hagens Berman — Neutral
SJM GlobeNewsWire — August 01, 2025SAN FRANCISCO, Aug. 01, 2025 (GLOBE NEWSWIRE) -- On June 10, 2025, investors in The J.M. Smucker Company (NYSE: SJM) saw the price of their shares decline over 15% after the company announced disappointing Q4 2025 financial results.

Frequency Electronics Announces 2025 Quantum Sensing Summit in New York City — Neutral
FEIM GlobeNewsWire — August 01, 2025MITCHEL FIELD, N.Y., Aug. 01, 2025 (GLOBE NEWSWIRE) -- Frequency Electronics, Inc. (“FEI” or the “Company”) (NASDAQ-FEIM), a leading provider of precision timing and frequency control products, today announced it will host the 2025 Quantum Sensing Summit on October 29–30, 2025, in New York City.

Zillow hit with federal copyright lawsuit over 47K allegedly stolen property photos — Negative
Z ZG Fox Business — August 01, 2025CoStar files lawsuit against Zillow claiming systematic copyright infringement of photographs distributed across Zillow's network. Many of the images have the CoStar watermark.

Scott Bauer (@ProsperTradingAcademy) joins Trading 360 with a trio of August expiry example options trades. First, he focuses on Chewy (CHWY) highlighting technical support around the stock's 200-day moving average.

AB InBev Q2 Earnings Beat Estimates, Revenues Miss on Soft Volumes — Positive
BUD Zacks Investment Research — August 01, 2025BUD beats Q2 EPS estimates on cost discipline and brand strength, but revenues miss amid soft China & Brazil volumes.

CORT's Q2 Earnings Top Mark, Revenues Lag, '25 View Cut, Stock Down — Neutral
CORT Zacks Investment Research — August 01, 2025Corcept beats second-quarter earnings forecasts but misses the same for revenues. The company trims its 2025 revenue outlook.

IRADIMED CORPORATION (IRMD) Q2 2025 Earnings Call Transcript — Neutral
IRMD Seeking Alpha — August 01, 2025IRADIMED CORPORATION (NASDAQ:IRMD ) Q2 2025 Earnings Conference Call August 1, 2025 11:00 AM ET Company Participants John F. Glenn - CFO & Corporate Secretary Roger E.

Novo Nordisk's Alhemo Wins FDA Nod, Expanding Subcutaneous Option For Hemophilia Patients — Positive
NVO Benzinga — August 01, 2025The U.S. Food and Drug Administration approved on Friday, the Novo Nordisk A/S NVO Alhemo (concizumab-mtci) injection as a once-daily prophylaxis to prevent or reduce the frequency of bleeding episodes in patients 12 years of age and older with hemophilia A or B without inhibitors.

Custom Truck One Source, Inc. (CTOS) Q2 2025 Earnings Conference Call Transcript — Neutral
CTOS Seeking Alpha — August 01, 2025Custom Truck One Source, Inc. (NYSE:CTOS ) Q2 2025 Earnings Call July 31, 2025 9:00 AM ET Company Participants Brian Perman - Vice President of Investor Relations Christopher J. Eperjesy - Chief Financial Officer Ryan McMonagle - CEO & Director Conference Call Participants Naim Gavriel Kaplan - Deutsche Bank AG, Research Division Operator Hello, and welcome to the Custom Truck One Source Inc. Second Quarter 2025 Earnings Conference Call.

Franklin Resources, Inc. (BEN) Q3 2025 Earnings Call Transcript — Neutral
BEN Seeking Alpha — August 01, 2025Franklin Resources, Inc. (NYSE:BEN ) Q3 2025 Earnings Conference Call August 1, 2025 10:00 AM ET Company Participants Adam Benjamin Spector - Executive VP & Head of Global Distribution Jennifer M. Johnson - President, CEO & Director Matthew Nicholls - Executive VP, CFO & COO Selene Oh - Head of Investor Relations Conference Call Participants Alexander Blostein - Goldman Sachs Group, Inc., Research Division Brian Bertram Bedell - Deutsche Bank AG, Research Division Daniel Thomas Fannon - Jefferies LLC, Research Division Glenn Paul Schorr - Evercore ISI Institutional Equities, Research Division Kenneth Brooks Worthington - JPMorgan Chase & Co, Research …

CRM vs. NOW: Which Workflow Automation Stock Has More Upside? — Positive
CRM NOW Zacks Investment Research — August 01, 2025ServiceNow NOW and Salesforce CRM are leading workflow automation platforms, helping enterprises streamline operations through cloud-based software and AI-powered tools. Platforms provided by these companies are widely used by large enterprises to drive efficiency and improve service delivery.

What Makes Tenable (TENB) a New Buy Stock — Positive
TENB Zacks Investment Research — August 01, 2025Tenable (TENB) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Evercore (EVR) Is Up 0.86% in One Week: What You Should Know — Positive
EVR Zacks Investment Research — August 01, 2025Does Evercore (EVR) have what it takes to be a top stock pick for momentum investors? Let's find out.

Coupang (CPNG) Upgraded to Buy: Here's What You Should Know — Positive
CPNG Zacks Investment Research — August 01, 2025Coupang (CPNG) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Metalla Royalty & Streaming Ltd. (MTA) is a Great Momentum Stock: Should You Buy? — Positive
MTA Zacks Investment Research — August 01, 2025Does Metalla Royalty & Streaming Ltd. (MTA) have what it takes to be a top stock pick for momentum investors?
